- Citations, last 5 years
- 186
- Works, last 5 years
- 12
- h-index
- 36
- Scientists listed
- 2
- Grants since 2016
- 4
Grants received
2025–2026 · research · R43
Novel Antimicrobial Approach to Treat Chemoradiation Resistant Cervical Cancer by Selectively Inhibiting Lactobacillus iners
Laurel A. Lagenaur · Osel (United States) · funded by National Institutes of Health
2020–2023 · research · R44
MucoCept-CVN, a genetically enhanced vaginal Lactobacillus strain for the prevention of HIV acquisition in women: Finalization of formulation for the first-in-human clinical trial
Laurel A. Lagenaur · Osel (United States) · funded by National Institutes of Health
2020–2022 · research · R44
MucoCept-CVN, a genetically enhanced vaginal Lactobacillus strain for the prevention of HIV acquisition in women: Finalization of formulation for the first-in-human clinical trial
Laurel A. Lagenaur · Osel (United States) · funded by National Institutes of Health
2016–2018 · research · R43
Development of a rapid point of care diagnostic,to monitor MucoCept-CVN, an HIV-targeted biotherapy,
Laurel A. Lagenaur · Osel (United States) · funded by National Institutes of Health